Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rite Aid Medicaid settlement

Executive Summary

Rite Aid second quarter results include "an accrual of $7.1 mil. for the settlement of legal matters with the Department of Justice and multiple state attorneys general related to our former reimbursement practices relating to partially filled prescriptions and fully filled prescriptions that are not picked up by the ordering customers," the chain drug store tells analysts. Rite Aid said it was not required to enter into a corporate integrity agreement. Other recent chain drug settlements related to partial script filling are CVS ($4 mil.), Eckerd ($1.7 mil.) and Walgreens ($7.6 mil.) (1"The Pink Sheet" Sept. 3, p. 12)

You may also be interested in...



Rite Aid, Wal-Mart Settle Rx “Partial Fill” Cases; Govt. Collects $10 Mil.

Rite Aid and Wal-Mart are the fourth and fifth national drug store chains to reach settlements with the Department of Justice regarding partially filled prescriptions for federal health care beneficiaries

Rite Aid, Wal-Mart Settle Rx “Partial Fill” Cases; Govt. Collects $10 Mil.

Rite Aid and Wal-Mart are the fourth and fifth national drug store chains to reach settlements with the Department of Justice regarding partially filled prescriptions for federal health care beneficiaries

CVS Integrity Agreement With HHS IG Endorses Partial Rx Fill Policy

CVS' corporate integrity agreement with the HHS Inspector General endorses the drug chain's procedures for handling partially filled prescriptions.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel